ARROWHEAD PHARMACEUTICALS, INC. Research And Development Expense

Quick Answer

ARROWHEAD PHARMACEUTICALS, INC. reported Research And Development Expense of $607.16 million for the year ending 2025.

  • ARROWHEAD PHARMACEUTICALS, INC. showed an increase of +20.0% in Research And Development Expense from 2024 to 2025.
  • This data is from ARROWHEAD PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on November 25, 2025.
  • XBRL data for this metric is available from 2011 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2011 to 2025), ARROWHEAD PHARMACEUTICALS, INC.'s Research And Development Expense has grown by 18,423.6%.
  • Historical annual values: Fiscal year 2025: $607.16 million | Fiscal year 2024: $505.87 million | Fiscal year 2023: $353.19 million | Fiscal year 2015: $47.27 million | Fiscal year 2014: $23.14 million | Fiscal year 2013: $8.71 million | Fiscal year 2012: $5.39 million | Fiscal year 2011: $3.28 million.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: